Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
498,551,233
-
Share change
-
-6,087,902
-
Total reported value
-
$36,115,652,063
-
Put/Call ratio
-
70%
-
Price per share
-
$72.48
-
Number of holders
-
1,190
-
Value change
-
-$465,368,232
-
Number of buys
-
483
-
Number of sells
-
607
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q1 2025
As of 31 Mar 2025,
Edwards Lifesciences Corp - Common Stock (EW) was held by
1,190 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
498,551,233 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Fisher Asset Management, LLC, and JENNISON ASSOCIATES LLC.
This page lists
1,195
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.